vantocil has been researched along with amikacin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashar, JN; Garg, P; Mathur, A; Nalamada, S; Taneja, M | 1 |
| Knafl, D; Thalhammer, F; Vossen, MG | 1 |
2 other study(ies) available for vantocil and amikacin
| Article | Year |
|---|---|
Microbial keratitis following vegetative matter injury.
Topics: Acanthamoeba; Adult; Amebiasis; Amikacin; Anti-Bacterial Agents; Biguanides; Corneal Ulcer; Disinfectants; Eye Infections, Bacterial; Eye Infections, Fungal; Eye Injuries; Female; Humans; Keratitis; Male; Plants; Prevalence; Retrospective Studies; Risk Factors | 2013 |
In-vitro release pharmacokinetics of amikacin, teicoplanin and polyhexanide in a platelet rich fibrin-layer (PRF)-a laboratory evaluation of a modern, autologous wound treatment.
Topics: Agar; Amikacin; Anti-Bacterial Agents; Bandages; Biguanides; Delayed-Action Preparations; Disk Diffusion Antimicrobial Tests; Drug Liberation; Fibrin; Humans; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Models, Biological; Platelet-Derived Growth Factor; Platelet-Rich Plasma; Pseudomonas aeruginosa; Teicoplanin; Wound Healing | 2017 |